Project Grant R01EY039573
- The National Eye Institute, a division of the Department of Health and Human Services National Institutes of Health, awarded $451,871 to the University of Texas at Austin on September 1, 2026, under the Vision Research program (CFDA 93.867, Assistance Listing program R01EY038362). The award funds research on anticipation and integration in the primate visual system, specifically investigating how temporal prediction shapes neural computation and visual representation. The project will test the...
- The National Eye Institute, part of the Department of Health and Human Services National Institutes of Health, awarded $2,271,828 to The University of Texas Southwestern Medical Center on September 1, 2026, under the Vision Research program (CFDA 93.867). The recipient will conduct research into the cellular and molecular mechanisms governing optic nerve myelin integrity, with emphasis on understanding how myelin whorls—multilayered degenerative myelin structures that appear in demyelinating...
- The National Eye Institute awarded the University of Texas at Austin $696,503 on April 1, 2026, under the Vision Research program (CFDA 93.867) to investigate circuit mechanisms underlying invariant representations in visual processing. The award, designated R01EY037544, supports a five-year project through March 31, 2031, with work performed in Austin, Texas. The research dissects how the visual system transforms sensory inputs into increasingly invariant representations that remain stable...
- The National Eye Institute, part of the Department of Health and Human Services National Institutes of Health, awarded The Methodist Hospital Research Institute $224,100 on June 1, 2026, under the Vision Research program (CFDA 93.867) to investigate how direct connections between primary visual cortex and prefrontal cortex interact with the pulvinar nucleus of the thalamus to shape visual perception and visually-guided decision-making in nonhuman primates. The recipient will employ focused...
- The National Eye Institute awarded The University of Texas Southwestern Medical Center $456,500 on July 1, 2026, under the Vision Research program (CFDA 93.867, Assistance Listing) for spatial molecular profiling of optic nerve injury and assessment of extracellular matrix (ECM) proteins. The research examines why regenerated retinal ganglion cell (RGC) axons fail to reach the brain after optic nerve injury, instead following circuitous pathways within fibrotic scars—a phenomenon the...
- The National Eye Institute, part of the Department of Health and Human Services National Institutes of Health, awarded The University of Chicago $929,806 on September 30, 2025, under the Vision Research program (CFDA 93.867). The award funds research into synaptic development of the retinogeniculate pathway—the neural circuit connecting the eyes to the brain—with investigation focused on how neurons form correct connections during childhood development and how visual experience shapes that...
- The National Eye Institute awarded The Schepens Eye Research Institute $858,394 on August 1, 2026, under the Vision Research program (CFDA 93.867) to develop multimodal foundation models for eye disease screening and prognosis. The research develops a vision-language foundation model trained on pairs of retinal images and clinical notes to enable downstream supervised models for detection and progression prediction of age-related macular degeneration, diabetic retinopathy, and glaucoma. The...
- The National Eye Institute, part of the Department of Health and Human Services National Institutes of Health, awarded $624,743 to the Regents of the University of California, doing business as University of California, Berkeley, on May 1, 2026, under the Vision Research program (CFDA 93.867). The award funds research into the function and regulation of constitutive prostaglandin D2 and DP receptor signaling in retinal health and neurodegeneration. The research investigates the physiological and...
- Federal Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded $830,024 to The Regents of The University of Colorado-Denver for a two-year project (September 1, 2025 – August 31, 2027) titled "Elucidating Competence and Fate Choice Dynamics During Retinal Development." The project aims to advance understanding of retinal cell development mechanisms by investigating how Notch signaling regulates cell fate decisions in the...
- The National Eye Institute, part of the Department of Health and Human Services, awarded $458,288 to the University of Washington on May 1, 2026, under the Vision Research program (CFDA 93.867, Assistance Listing designation Project Grant). The award funds research into stimulation of regeneration in the human retina. The investigator team will test whether expressing the proneural regulatory gene ASCL1 in Müller glia can induce regeneration of retinal neurons in human tissue and adult non-human...
The National Eye Institute, a component of the Department of Health and Human Services National Institutes of Health, awarded $513,299 to the University of Texas at Arlington on September 1, 2026, under the Vision Research program (CFDA 93.867) for a Project Grant supporting fundamental research in transcriptional regulation underlying ocular health and disease. The award funds development of TREX, a variational Bayesian framework designed to identify tissue-specific transcriptional regulators associated with vision and eye disease by leveraging next-generation sequencing data from various eye tissues. The project also introduces SIDETR, a Bayesian multi-instance learning model that deconvolves bulk transcription factor ChIP-seq data using single-cell ATAC-seq and RNA-seq information to reveal cell-type-specific binding landscapes of individual transcriptional regulators. These methods address current computational limitations in transcriptional regulator identification, including inadequate handling of tissue heterogeneity, lack of uncertainty quantification, and poor scalability. The research aims to build a comprehensive reference library for identifying vision-critical transcriptional regulators at cellular resolution. Performance occurs at the University of Texas at Arlington's Office of Research Administration in Arlington, Texas, with a period of performance extending through February 28, 2030. The assistance type is a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $513.3k | 8/26/26 |